Kiesslich R, Kanzler S, Vieth M, Moehler M, Neidig J, Thanka Nadar B J, Schilling D, Burg J, Nafe B, Neurath M F, Galle P R
1st Medical Clinic, Johannes Gutenberg University Mainz, Germany.
Dig Dis. 2004;22(2):221-7. doi: 10.1159/000080323.
More than half the patients with gastroesophageal reflux disease (GERD) show no endoscopic abnormality or minimal change esophagitis (non-erosive reflux disease, NERD). We investigated the value of endoscopic and histological markers for the prediction of NERD before and after treatment with 20 mg esomeprazole.
Between July and October 2002, consecutive patients presenting for upper endoscopy were stratified into GERD and non-reflux patients (control group) with the help of a questionnaire. The endoscopist was blind to the presence of reflux symptoms. Using magnifying endoscopes minimal change esophagitis was defined by the presence of vascular injection or vascular spots above the Z-line, villous mucosal surface and islands of squamous cell epithelium below the Z-line. Targeted and random biopsies were taken below and above the Z-line. Patients with endoscopically visible classical signs of esophagitis (Los Angeles A-D) or histologically proven Barrett's esophagus were not further investigated in the study (drop out). The esophageal specimens were histologically evaluated for erosions, infiltration with leukocytes, hyperplasia of basal cells and length of papillae. Patients with NERD were treated with 20 mg esomeprazole/day for 4 weeks and reevaluated by endoscopy as described before.
39 patients with heartburn and 39 patients without reflux symptoms (controls) were finally included in the analysis (per protocol). Patients with NERD significantly (p = 0.005) more often showed endoscopic signs of minimal change esophagitis (27/39) than the control group (8/39). An increased length of papillae (14/39 versus 2/39; p = 0.005) and basal cell hyperplasia (17/39 versus 4/39; p = 0.009) were significantly more common in the heartburn group. After treatment with esomeprazole, no significant endoscopic or histological differences between the NERD and control group could be observed.
Minimal change esophagitis can be seen with high resolution magnifying endoscopy. By combining endoscopic and histological markers NERD can be predicted with a sensitivity of 62% and a specificity of 74%. Treatment with esomeprazole for 4 weeks reverses the slight alterations to normal.
超过半数的胃食管反流病(GERD)患者内镜检查无异常或仅有轻微食管炎改变(非糜烂性反流病,NERD)。我们研究了内镜和组织学标志物在20毫克埃索美拉唑治疗前后对NERD预测的价值。
2002年7月至10月期间,连续接受上消化道内镜检查的患者借助问卷被分为GERD组和非反流患者(对照组)。内镜检查医师对反流症状的存在不知情。使用放大内镜,最小变化性食管炎定义为Z线以上存在血管充血或血管斑、Z线以下绒毛状黏膜表面和鳞状上皮岛。在Z线上下进行靶向活检和随机活检。内镜可见典型食管炎体征(洛杉矶分级A - D级)或组织学证实为巴雷特食管的患者不在本研究中进一步调查(排除)。对食管标本进行组织学评估,观察有无糜烂、白细胞浸润、基底细胞增生及乳头长度。NERD患者接受20毫克埃索美拉唑/天治疗4周,并按上述方法再次进行内镜评估。
最终纳入分析39例有烧心症状的患者和39例无反流症状的患者(对照组)(符合方案分析)。NERD患者出现最小变化性食管炎内镜表现(27/39)的频率显著高于对照组(8/39)(p = 0.005)。烧心组乳头长度增加(14/39对2/39;p = 0.005)和基底细胞增生(17/39对4/39;p = 0.009)更为常见。埃索美拉唑治疗后,NERD组和对照组在内镜或组织学上无显著差异。
高分辨率放大内镜可观察到最小变化性食管炎。结合内镜和组织学标志物可预测NERD,敏感性为62%,特异性为74%。埃索美拉唑治疗4周可使轻微改变恢复正常。